Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1988 Dec;9:41–45.

The HL60 cell line: a model system for studying human myeloid cell differentiation.

G D Birnie 1
PMCID: PMC2149104  PMID: 3076064

Abstract

The HL60 cell line was established in 1977 from a patient with acute myeloid leukaemia. The cells largely resemble promyelocytes but can be induced to differentiate terminally in vitro. Some reagents cause HL60 cells to differentiate to granulocyte-like cells, others to monocyte/macrophage-like cells. The HL60 cell genome contains an amplified c-myc proto-oncogene; c-myc mRNA levels are correspondingly high in undifferentiated cells but decline rapidly following induction of differentiation. These features have made the HL60 cell line an attractive model for studies of human myeloid cell differentiation. This review summarizes the major properties of HL60 cells, describes some aspects of the regulation of gene expression in differentiating HL60 cells, including a novel interaction between transcriptional and post-transcriptional controls, and discusses the possible involvement of c-myc in proliferation and differentiation.

Full text

PDF
41

Images in this article

43Figure 2
on p.43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armelin H. A., Armelin M. C., Kelly K., Stewart T., Leder P., Cochran B. H., Stiles C. D. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature. 1984 Aug 23;310(5979):655–660. doi: 10.1038/310655a0. [DOI] [PubMed] [Google Scholar]
  2. Bender T. P., Thompson C. B., Kuehl W. M. Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science. 1987 Sep 18;237(4821):1473–1476. doi: 10.1126/science.3498214. [DOI] [PubMed] [Google Scholar]
  3. Bentley D. L., Groudine M. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature. 1986 Jun 12;321(6071):702–706. doi: 10.1038/321702a0. [DOI] [PubMed] [Google Scholar]
  4. Bianchi Scarrà G. L., Romani M., Coviello D. A., Garrè C., Ravazzolo R., Vidali G., Ajmar F. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease. Cancer Res. 1986 Dec;46(12 Pt 1):6327–6332. [PubMed] [Google Scholar]
  5. Bos J. L., Verlaan-de Vries M., Jansen A. M., Veeneman G. H., van Boom J. H., van der Eb A. J. Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res. 1984 Dec 11;12(23):9155–9163. doi: 10.1093/nar/12.23.9155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A. 1980 May;77(5):2936–2940. doi: 10.1073/pnas.77.5.2936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown G., Bunce C. M., Howie A. J., Lord J. M. Stochastic or ordered lineage commitment during hemopoiesis? Leukemia. 1987 Feb;1(2):150–153. [PubMed] [Google Scholar]
  8. Colbert D. A., Fontana J. A., Bode U., Deisseroth A. B. Changes in the translational activity of polyadenylated messenger RNA of HL60 promyelocytic leukemia cells associated with myeloid or macrophage differentiation. Cancer Res. 1983 Jan;43(1):229–234. [PubMed] [Google Scholar]
  9. Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
  10. Collins S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987 Nov;70(5):1233–1244. [PubMed] [Google Scholar]
  11. Collins S., Groudine M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature. 1982 Aug 12;298(5875):679–681. doi: 10.1038/298679a0. [DOI] [PubMed] [Google Scholar]
  12. Coppola J. A., Cole M. D. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature. 1986 Apr 24;320(6064):760–763. doi: 10.1038/320760a0. [DOI] [PubMed] [Google Scholar]
  13. Dalla-Favera R., Wong-Staal F., Gallo R. C. Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature. 1982 Sep 2;299(5878):61–63. doi: 10.1038/299061a0. [DOI] [PubMed] [Google Scholar]
  14. Dalton W. T., Jr, Ahearn M. J., McCredie K. B., Freireich E. J., Stass S. A., Trujillo J. M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood. 1988 Jan;71(1):242–247. [PubMed] [Google Scholar]
  15. Davis R. C., Thomason A. R., Fuller M. L., Slovin J. P., Chou C. C., Chada S., Gatti R. A., Salser W. A. mRNA species regulated during the differentiation of HL-60 cells to macrophages and neutrophils. Dev Biol. 1987 Jan;119(1):164–174. doi: 10.1016/0012-1606(87)90218-1. [DOI] [PubMed] [Google Scholar]
  16. Dean M., Levine R. A., Campisi J. c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest. Mol Cell Biol. 1986 Feb;6(2):518–524. doi: 10.1128/mcb.6.2.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Eick D., Bornkamm G. W. Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. Nucleic Acids Res. 1986 Nov 11;14(21):8331–8346. doi: 10.1093/nar/14.21.8331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ely C. M., Leftwich J. A., Chenevix-Trench G., Hall R. E., Westin E. H. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3. Cancer Res. 1987 Sep 1;47(17):4595–4600. [PubMed] [Google Scholar]
  19. Evan G. I., Hancock D. C. Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell. 1985 Nov;43(1):253–261. doi: 10.1016/0092-8674(85)90030-3. [DOI] [PubMed] [Google Scholar]
  20. Fibach E., Peled T., Treves A., Kornberg A., Rachmilewitz E. A. Modulation of the maturation of human leukemic promyelocytes (HL-60) to granulocytes or macrophages. Leuk Res. 1982;6(6):781–790. doi: 10.1016/0145-2126(82)90060-1. [DOI] [PubMed] [Google Scholar]
  21. Filmus J., Buick R. N. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells. Cancer Res. 1985 Feb;45(2):822–825. [PubMed] [Google Scholar]
  22. Fontana J. A., Colbert D. A., Deisseroth A. B. Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3863–3866. doi: 10.1073/pnas.78.6.3863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 1979 Sep;54(3):713–733. [PubMed] [Google Scholar]
  24. Graham S. V., Birnie G. D. Concomitant transcriptional and post-transcriptional control of mRNA abundance during human myeloid cell differentiation. Nucleic Acids Res. 1988 Mar 25;16(6):2523–2535. doi: 10.1093/nar/16.6.2523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Graham S. V., Tindle R. W., Birnie G. D. Variation in myc gene amplification and expression in sublines of HL60 cells. Leuk Res. 1985;9(2):239–247. doi: 10.1016/0145-2126(85)90086-4. [DOI] [PubMed] [Google Scholar]
  26. Greaves M. F., Chan L. C., Furley A. J., Watt S. M., Molgaard H. V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood. 1986 Jan;67(1):1–11. [PubMed] [Google Scholar]
  27. Holt J. T., Redner R. L., Nienhuis A. W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol. 1988 Feb;8(2):963–973. doi: 10.1128/mcb.8.2.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Huebner K., Isobe M., Croce C. M., Golde D. W., Kaufman S. E., Gasson J. C. The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly. Science. 1985 Dec 13;230(4731):1282–1285. doi: 10.1126/science.2999978. [DOI] [PubMed] [Google Scholar]
  29. Isobe M., Emanuel B. S., Givol D., Oren M., Croce C. M. Localization of gene for human p53 tumour antigen to band 17p13. Nature. 1986 Mar 6;320(6057):84–85. doi: 10.1038/320084a0. [DOI] [PubMed] [Google Scholar]
  30. Kaczmarek L., Hyland J. K., Watt R., Rosenberg M., Baserga R. Microinjected c-myc as a competence factor. Science. 1985 Jun 14;228(4705):1313–1315. doi: 10.1126/science.4001943. [DOI] [PubMed] [Google Scholar]
  31. Kohl N. E., Ruley H. E. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes. Oncogene. 1987;2(1):41–48. [PubMed] [Google Scholar]
  32. Lachman H. M., Skoultchi A. I. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature. 1984 Aug 16;310(5978):592–594. doi: 10.1038/310592a0. [DOI] [PubMed] [Google Scholar]
  33. Land H., Parada L. F., Weinberg R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 1983 Aug 18;304(5927):596–602. doi: 10.1038/304596a0. [DOI] [PubMed] [Google Scholar]
  34. Lee W. M., Schwab M., Westaway D., Varmus H. E. Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol. 1985 Dec;5(12):3345–3356. doi: 10.1128/mcb.5.12.3345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McCachren S. S., Jr, Nichols J., Kaufman R. E., Niedel J. E. Dibutyryl cyclic adenosine monophosphate reduces expression of c-myc during HL-60 differentiation. Blood. 1986 Aug;68(2):412–416. [PubMed] [Google Scholar]
  36. McCulloch E. A. Lineage infidelity or lineage promiscuity? Leukemia. 1987 Mar;1(3):235–235. [PubMed] [Google Scholar]
  37. Munroe D., Sugiura M., Griffin J., Kufe D. Effect of ara-A on differentiation and proliferation of HL-60 cells. Leuk Res. 1984;8(3):355–361. doi: 10.1016/0145-2126(84)90075-4. [DOI] [PubMed] [Google Scholar]
  38. Murray M. J., Cunningham J. M., Parada L. F., Dautry F., Lebowitz P., Weinberg R. A. The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell. 1983 Jul;33(3):749–757. doi: 10.1016/0092-8674(83)90017-x. [DOI] [PubMed] [Google Scholar]
  39. Neel B. G., Jhanwar S. C., Chaganti R. S., Hayward W. S. Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7842–7846. doi: 10.1073/pnas.79.24.7842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nowell P., Finan J., Dalla-Favera R., Gallo R. C., ar-Rushdi A., Romanczuk H., Selden J. R., Emanuel B. S., Rovera G., Croce C. M. Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line. Nature. 1983 Dec 1;306(5942):494–497. doi: 10.1038/306494a0. [DOI] [PubMed] [Google Scholar]
  41. Parmley R. T., Akin D. T., Barton J. C., Gilbert C. S., Kinkade J. M., Jr Cytochemistry and ultrastructural morphometry of cultured HL60 myeloid leukemia cells. Cancer Res. 1987 Sep 15;47(18):4932–4940. [PubMed] [Google Scholar]
  42. Persson H., Leder P. Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science. 1984 Aug 17;225(4663):718–721. doi: 10.1126/science.6463648. [DOI] [PubMed] [Google Scholar]
  43. Siebenlist U., Bressler P., Kelly K. Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells. Mol Cell Biol. 1988 Feb;8(2):867–874. doi: 10.1128/mcb.8.2.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tsiftsoglou A. S., Robinson S. H. Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells. Int J Cell Cloning. 1985 Nov;3(6):349–366. doi: 10.1002/stem.5530030602. [DOI] [PubMed] [Google Scholar]
  45. Wickstrom E. L., Bacon T. A., Gonzalez A., Freeman D. L., Lyman G. H., Wickstrom E. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1028–1032. doi: 10.1073/pnas.85.4.1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wolf D., Rotter V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci U S A. 1985 Feb;82(3):790–794. doi: 10.1073/pnas.82.3.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wolman S. R., Lanfrancone L., Dalla-Favera R., Ripley S., Henderson A. S. Oncogene mobility in a human leukemia line HL-60. Cancer Genet Cytogenet. 1985 Jun;17(2):133–141. doi: 10.1016/0165-4608(85)90023-8. [DOI] [PubMed] [Google Scholar]
  48. Yokoyama K., Imamoto F. Transcriptional control of the endogenous MYC protooncogene by antisense RNA. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7363–7367. doi: 10.1073/pnas.84.21.7363. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES